Nonalcoholic steatohepatitis and obesity: influence of key risk factors on the development of obstetric and perinatal complications in pregnant women

被引:1
作者
Bahnii, L., V [1 ]
Heriak, S. M. [1 ]
Bahnii, N., I [1 ]
机构
[1] Ivan Horbachevsky Ternopil Natl Med Univ, Minist Hlth Ukraine, Dept Obstet & Gynecol 2, Ternopol, Ukraine
关键词
non-alcoholic steatohepatitis; obesity; body mass index; lipid metabolism; pregnancy complications; FATTY LIVER-DISEASE; OUTCOMES;
D O I
10.14739/2310-1210.2022.3.252654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study is to assess the development of obstetric and perinatal complications in obese pregnant women with non-alcoholic steatohepatitis (NASH) depending on changes in blood lipid spectrum and body mass index (BMI). Materials and methods. We examined 98 pregnant women with non-alcoholic fatty liver disease (NAFLD) at the stage of NASH in combination with obesity. The control group consisted of 30 healthy pregnant women. All pregnant women with NAFLD and abdominal obesity were divided into 3 groups depending on BMI: Group I -26 pregnant women with BMI 25.0-29.9 kg/m(2), Group II - 48 pregnant women with BMI 30.0-34.9 kg/m(2), Group III - 24 pregnant women with BMI 35.0-39.9 kg/m(2). Correlations of obstetric complications depending on changes in lipid metabolism and BMI were determined. Results. The analysis of obstetric complications revealed 3.4 times higher risk of early miscarriage in group I, 5.6 times - in group II, 7.5 times - in group III compared the control group (P < 0.05); early gestosis occurred 1.9 times more often in group I, 2.5 times - in group II, 3.3 times - in group III as compared to that in pregnant women of the control group (P < 0.05); the threat of premature birth was found 3.4 times more frequently in group I, 5.6 times - in group II, 7.5 times - in group III as compared with the control group (P < 0.05). Group I patients developed placental dysfunction with a frequency of 2.3 times, group II - of 4.0 times, and group III - of 6.3 times greater than pregnant women of the control group (P < 0.05), and moderate preeclampsia was diagnosed in overweight pregnant women, as well as in women with grade I and grade II-III obesity 2.3 times, 4.7 times and 5.6 times as often, respectively, as in the control group (P < 0.05). Correlation analysis showed correlations between lipid metabolism indicators and an increase in BMI. Conclusions, Obese pregnant women with NAFLD at the stage of NASH were found to have significantly more frequent obstetric and perinatal complications as well as lipid profile abnormalities correlating with increased BMI, which may be due to the presence of NASH and functional liver failure.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 21 条
  • [1] Effects of maternal obesity on antenatal, perinatal and neonatal outcomes
    Avci, Muhittin Eftal
    Sanlikan, Fatih
    Celik, Mehmet
    Avci, Anil
    Kocaer, Mustafa
    Gocmen, Ahmet
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (17) : 2080 - 2083
  • [2] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357
  • [3] Endothelial dysfunction in pregnancy metabolic disorders
    Echeverria, Cesar
    Eltit, Felipe
    Santibanez, Juan F.
    Gatica, Sebastian
    Cabello-Verrugio, Claudio
    Simon, Felipe
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (02):
  • [4] Mechanisms of NAFLD development and therapeutic strategies
    Friedman, Scott L.
    Neuschwander-Tetri, Brent A.
    Rinella, Mary
    Sanyal, Arun J.
    [J]. NATURE MEDICINE, 2018, 24 (07) : 908 - 922
  • [5] Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease
    Hagstrom, Hannes
    Hoijer, Jonas
    Ludvigsson, Jonas F.
    Bottai, Matteo
    Ekbom, Anders
    Hultcrantz, Rolf
    Stephansson, Olof
    Stokkeland, Knut
    [J]. LIVER INTERNATIONAL, 2016, 36 (02) : 268 - 274
  • [6] Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study
    Herath, Rasika Pradeep
    Siriwardana, Shirom R.
    Ekanayake, Chanil D.
    Abeysekara, Vikum
    Kodithuwakku, Sajith U. A.
    Herath, Himali P.
    [J]. PLOS ONE, 2019, 14 (04):
  • [7] Hershman Melissa, 2019, Gastroenterol Hepatol (N Y), V15, P221
  • [8] Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
    Koehler, Edith M.
    Plompen, Elisabeth P. C.
    Schouten, Jeoffrey N. L.
    Hansen, Bettina E.
    Murad, Sarwa Darwish
    Taimr, Pavel
    Leebeek, Frank W. G.
    Hofman, Albert
    Stricker, Bruno H.
    Castera, Laurent
    Janssen, Harry L. A.
    [J]. HEPATOLOGY, 2016, 63 (01) : 138 - 147
  • [9] Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus
    Lee, Seung Mi
    Kwak, Soo Heon
    Koo, Ja Nam
    Oh, Ig Hwan
    Kwon, Jeong Eun
    Kim, Byoung Jae
    Kim, Sun Min
    Kim, Sang Youn
    Kim, Gyoung Min
    Joo, Sae Kyung
    Koo, Bo Kyung
    Shin, Sue
    Vixay, Chanthalakeo
    Norwitz, Errol R.
    Park, Chan-Wook
    Jun, Jong Kwan
    Kim, Won
    Park, Joong Shin
    [J]. DIABETOLOGIA, 2019, 62 (02) : 238 - 248
  • [10] Obstetric Outcomes in Women with Nonalcoholic Fatty Liver Disease
    Lee, Yeon Woo
    Yarrington, Christina D.
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2017, 15 (08) : 387 - 392